Protocol No
BEIGENE-BGB-11417-105
Staff Member
Binod Dhakal
Phase
I/II
Summary
This study will look at the safety and efficacy of an investigational drug currently known as BGB-11417 when given together with a drug called dexamethasone or when given together with dexamethasone and carfilzomib.
Objective
A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to
Determine the Safety and Efficacy of BGB-11417 in Combination With Dexamethasone andCarfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)
Determine the Safety and Efficacy of BGB-11417 in Combination With Dexamethasone andCarfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov